
Erdomed capsules 300 mg
Active substance:
Each capsule contains 300 Erdomed mg Erdosteine.
Other ingredients: povidone, microcrystalline cellulose, magnesium stearate, gelatin, titanium dioxide (E171), yellow iron oxide (E172), indigotin (E132).
Other ingredients: sucrose, sodium benzoate, sodium starch glycolate, aspartame, citric flavor
Formulations and packaging:
Box of 10 capsules of 300 mg
Box of 20 capsules of 300 mg
Pharmacotherapeutic group
Mukolitik
Liquefying agent bronchial mucosa.
Witness
Mukolitik, liquefy secretions in acute and chronic diseases of the respiratory system.
Known hypersensitivity to Erdosteina and other ingredients. Due to the possible influence of metabolites of the product on the metabolism of methionine, it Erdomed is contraindicated in patients with liver cirrhosis and deficiency of the enzyme cystathionine synthetase.
Contains aspartame form - granules in sachets is contraindicated in phenylketonuria. ERDOMED granules contain sucrose. This should be considered in those with diabetes. Due to lack of data on the safety during pregnancy and lactation, Erdomed is contraindicated in pregnant and nursing mothers.
Adverse reactions
Following adoption of Erdomed not observed either gastrointestinal or systemic adverse effects.
There are no reports of interactions with other medicinal products and therefore can be administered with antibiotics, bronchodilators (theophylline or beta-2-agonists, drugs that inhibit cough, etc ...).
Special warnings and precautions for use
The granules contain sucrose. This should be considered in diabetic or low-calorie diet.
All formulations should be kept out of reach of children.
Oral dosage forms:
Capsules 150 mg: 1-2 capsules are taken 2-3 times daily.
Capsules 300 mg: 1 capsule 2-3 times daily.
Sachets 225 mg: In one sachet 2-3 times a day.
At temperatures below +25 ° C.
Expiration date
In intact packaging: 3 years
This medicinal product must not be used after the expiry date stated on the packaging.